Skip to content
2000
Volume 16, Issue 2
  • ISSN: 1389-5575
  • E-ISSN: 1875-5607

Abstract

The amino acid, L-Arginine (L-Arg) plays an important role in the cardiovascular system. Data from the literature show that L-Arg is the only substrate for the production of nitric oxide (NO), from which L-Arg develops its effects on the cardiovascular system. As a free radical, NO is synthesized in all mammalian cells by L-Arg with the activity of NO synthase (NOS). In states of hypertension, diabetes, hypercholesterolemia and vascular inflammation a disorder occurs in the metabolic pathway of the synthesis of NO from L-Arg which all together bring alterations of blood vessels. Experimental results obtained on animals, as well as clinical studies show that L-Arg has an effect on thrombocytes, on the process of coagulation and on the fibrolytic system. This mini review represents a summary of the latest scientific animal and human studies related to L-Arg and its mechanisms of actions with a focus on the role of L-Arg via NO pathway in cardiovascular disorders. Moreover, here we present data from recent animal and clinical studies suggesting that L-Arg could be one of the possible therapeutic molecules for improving the treatment of different cardiovascular disorders.

Loading

Article metrics loading...

/content/journals/mrmc/10.2174/1389557515666151016125826
2016-01-01
2025-08-18
Loading full text...

Full text loading...

/content/journals/mrmc/10.2174/1389557515666151016125826
Loading

  • Article Type:
    Research Article
Keyword(s): Amino acid; Arginase; cardiovascular disorders; cardiovascular system; L-Arg; NO; NOS
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test